AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bio-Rad to Report Fourth-Quarter and Full-Year 2019 Financial Results Thursday, February 13, 2020

February 4, 2020 GMT

HERCULES, Calif.--(BUSINESS WIRE)--Feb 3, 2020--

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2019 on Thursday, February 13, 2020, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the U.S., Conference ID: 1397614. You may also listen to the conference call live via a webcast that is available on the “Investor Relations” section of our website under “Quarterly Results” at bio-rad.com. The webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,100 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For more information, please visit bio-rad.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200203005842/en/

CONTACT: Investor Contact:

Bio-Rad Laboratories, Inc.

Ilan Daskal, Executive Vice President

& Chief Financial Officer

510-724-7000

investor_relations@bio-rad.comPress Contact:

Bio-Rad Laboratories, Inc.

Tina Cuccia, Corporate Communications

510-724-7000

tina_cuccia@bio-rad.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH HOSPITALS MANAGED CARE CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Bio-Rad Laboratories, Inc.

Copyright Business Wire 2020.

PUB: 02/03/2020 09:37 PM/DISC: 02/03/2020 09:37 PM

http://www.businesswire.com/news/home/20200203005842/en